Search
Log in
Sign up
Watch fullscreen
Biogen Plunges After FDA Says No to Alzheimer's Treatment
The Street
Follow
Like
Bookmark
Share
Add to Playlist
Report
5 years ago
Biogen stock plunges more than 30% after a Food and Drug Administration panel committee rules against giving the company's Alzheimer's drug the nod.
Category
🥇
Sports
Show less
Recommended
0:43
|
Up next
FDA Approves First Drug to Target Genetic Cause of ALS
Benzinga
1:30
FDA approves new Alzheimer’s drug from Eli Lilly
The Street
0:39
FDA Approves Eli Lilly's Alzheimer's Drug, Slowing the Progression of the Brain-Wasting Disease
Benzinga
0:47
Lilly Alzheimer's drug fails in big study
Wibbitz Top Stories
1:00
Medical advancements: New drug found to slow decline of Alzheimer’s by 35% in trial
Local TV
10:41
Novel Therapy Shows Promising Results In On-Going Trials, Receives 3 Orphan Drug Designations From The FDA
Benzinga
16:00
This Biotech Just Cleared A Big FDA Hurdle In Its Quest To Improve ADHD Treatment
Benzinga
1:31
New Drug Shows Promising Results in Fight Against Alzheimer's
Wibbitz Top Stories
0:48
Biogen Alzheimer's drug closer to approval
PDA Media
3:50
Landmark trial shows new drug can slow Alzheimer’s disease
ABC NEWS (Australia)
2:24
Biggest Pharmaceuticals Mergers And Acquisition in History
The Street
5:04
Families impacted by Alzheimer's express concerns over new drug Leqembi
23ABC News
0:42
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks
Benzinga
1:58
Dementia At the End of Life: What are the medications?
Healthfeedspanish
1:49
Drug trial shows treatment slows progress of disease
ABC NEWS (Australia)
0:48
New drug breakthrough gives hope for those with Alzheimer's
ODN
1:00
Alzheimer's: New drug dubbed 'beginning of the end' in search for treatment
National World - LocalTV
4:49
Fitness Business Are On The Rise — Here's Why
Forbes
10:32
Squirrel Ai Learning Founder Talks Revolutionizing K-12 Education For Millions Of Students
Forbes
4:38
To Understand How Trump Is Upending Washington, Speak To People From His Past
Forbes
0:30
Palantir Shares Drop Over 5% as CEO’s Stock Sale Plan and Pentagon Budget Cuts Fuel Investor Concerns
Benzinga
0:35
Florida Sues Target, Alleging DEI Efforts Misled Investors and Harmed Shareholders
Benzinga
1:36
Argentina’s President Faces Impeachment Over Crypto Plans
Benzinga
1:11
Apparently Suing NASA Is a Thing Especially After Space Debris Crashes into This Home
Amaze Lab
1:19
A Supernova May Have Altered the Trajectory of Life on Earth Forever
Amaze Lab